Loading...

Regencell Bioscience Holdings Limited

RGC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$15.05
$-0.13(-0.86%)

Regencell Bioscience Holdings Limited (RGC) Stock Chart & Performance Analysis

Explore Regencell Bioscience Holdings Limited’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-4.92%
5-Day Change
17.42%
1-Month Change
587.10%
3-Month Change
484.68%
6-Month Change
309.28%
Year-to-Date (YTD) Change
485.89%
1-Year Change
669.48%
3-Year Change
23.32%
5-Year Change
168.95%
All-Time (Max) Change
168.95%

Analyzing Regencell Bioscience Holdings Limited (RGC) Trends Across Multiple Time Frames

Regencell Bioscience Holdings Limited Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Regencell Bioscience Holdings Limited stock shows -4.92% 1-day change, indicating low volatility, while its 5-day change of 17.42% suggests a broader trend. Over a 1-month period, a 587.10% rise could signal a pushback, whereas a 3-month rise of 484.68% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 309.28% and a YTD rise of 485.89% might concern investors, but a 1-year gain of 669.48% and a 3-year increase of 23.32% could indicate resilience. The 5-year surge of 168.95% highlights strong historical growth, while the all-time return of 168.95% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;